Core Insights - Celanese reported a revenue of $2.42 billion for the quarter ended September 2025, reflecting an 8.7% decline year-over-year and falling short of the Zacks Consensus Estimate of $2.46 billion, resulting in a surprise of -1.69% [1] - The company's EPS was $1.34, down from $2.44 in the same quarter last year, but exceeded the consensus estimate of $1.27 by 5.51% [1] Financial Performance Metrics - Net Sales for the Acetyl Chain segment were $1.06 billion, slightly below the estimated $1.07 billion, marking a 10.8% decrease compared to the previous year [4] - Net Sales from Inter segment eliminations were reported at -$26 million, worse than the estimated -$22.39 million, but showed a 13% improvement year-over-year [4] - Engineered Materials segment reported Net Sales of $1.38 billion, matching estimates but down 6.6% from the year-ago quarter [4] - Operating EBITDA for the Acetyl Chain was $250 million, below the average estimate of $258.55 million [4] - Operating EBITDA for Other Activities was -$48 million, slightly better than the estimated -$49.88 million [4] - Engineered Materials segment achieved an Operating EBITDA of $315 million, exceeding the average estimate of $285.07 million [4] Stock Performance - Celanese shares have declined by 13.4% over the past month, contrasting with a 1.3% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]
Celanese (CE) Reports Q3 Earnings: What Key Metrics Have to Say